Deployment Expands Access to PacBio’s Highly Accurate Long Reads on the African Continent for a Variety of Applications, From Ethnic-Specific Reference Genomes to COVID-19 Research MENLO PARK, Calif. and PRETORIA,…
LabCorp, UC San Diego and the National Institute of Allergy and Infectious Diseases are among the organizations utilizing PacBio’s highly accurate long-read sequencing technology to study SARS-CoV-2 and the related…
MENLO PARK, Calif., March 18, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury…
MENLO PARK, Calif., March 05, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that industry…
Company Will Sponsor Sequencing and Assembly at UC Davis to Produce Reference-Grade Genomes for Several Ecologically Important Organisms in the State of California MENLO PARK, Calif. and DAVIS, Calif., Feb….
Dr. Denis Zaccarin Succeeds Phillips to Lead Research and Development MENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality…
Annual Revenue Increase of 16% Year Over Year MENLO PARK, Calif., Feb. 06, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its…
MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — In a release issued earlier today under the same headline by Pacific Biosciences of California, Inc. (NASDAQ: PACB), please note that…
MENLO PARK, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Fourth Quarter 2019 Financial Results…
SAN DIEGO & MENLO PARK, Calif.–(BUSINESS WIRE)–Jan. 2, 2020– Illumina, Inc. (NASDAQ:ILMN) and Pacific Biosciences of California, Inc. (NASDAQ:PACB) today announced that they have mutually agreed to terminate their merger…
MENLO PARK, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company’) today announced financial results for its third quarter ended September 30, 2019….
MENLO PARK, Calif., Oct. 10, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that more…
SOLVE-RD Program Will Sequence More Than 500 Human Genomes With SMRT Sequencing MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider…
MENLO PARK, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for its second quarter ended June 30, 2019. On April…
Service Provider Adds Two More Sequel II Systems to Meet Growing Demand for Long-Read Sequencing Data MENLO PARK, Calif., August 6, 2019 — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading…
If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.